Crestwood Advisors Group’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.66M | Sell |
100,729
-1
| -0% | -$36 | 0.07% | 154 |
|
|
2025
Q1 | $3.65M | Sell |
100,730
-1,000
| -1% | -$36.2K | 0.07% | 149 |
|
|
2024
Q4 | $4.28M | Buy |
101,730
+1,450
| +1% | +$61K | 0.08% | 136 |
|
|
2024
Q3 | $5.57M | Hold |
100,280
| – | – | 0.11% | 121 |
|
|
2024
Q2 | $4.12M | Buy |
100,280
+22
| +0% | +$904 | 0.09% | 131 |
|
|
2024
Q1 | $4.68M | Hold |
100,258
| – | – | 0.1% | 122 |
|
|
2023
Q4 | $4.79M | Hold |
100,258
| – | – | 0.11% | 122 |
|
|
2023
Q3 | $3.57M | Buy |
100,258
+70,350
| +235% | +$2.51M | 0.09% | 127 |
|
|
2023
Q2 | $1.38M | Hold |
29,908
| – | – | 0.04% | 120 |
|
|
2023
Q1 | $1.2M | Hold |
29,908
| – | – | 0.04% | 134 |
|
|
2022
Q4 | $1.39M | Hold |
29,908
| – | – | 0.05% | 125 |
|
|
2022
Q3 | $1.24M | Hold |
29,908
| – | – | 0.04% | 130 |
|
|
2022
Q2 | $1.78M | Hold |
29,908
| – | – | 0.06% | 122 |
|
|
2022
Q1 | $2.17M | Hold |
29,908
| – | – | 0.06% | 117 |
|
|
2021
Q4 | $2.52M | Hold |
29,908
| – | – | 0.07% | 116 |
|
|
2021
Q3 | $2.7M | Hold |
29,908
| – | – | 0.08% | 114 |
|
|
2021
Q2 | $2.85M | Hold |
29,908
| – | – | 0.08% | 110 |
|
|
2021
Q1 | $3.41M | Sell |
29,908
-1,100
| -4% | -$125K | 0.11% | 104 |
|
|
2020
Q4 | $4.29M | Hold |
31,008
| – | – | 0.14% | 100 |
|
|
2020
Q3 | $2.55M | Sell |
31,008
-1,100
| -3% | -$90.4K | 0.1% | 98 |
|
|
2020
Q2 | $2.51M | Sell |
32,108
-1,000
| -3% | -$78.2K | 0.1% | 101 |
|
|
2020
Q1 | $1.47M | Buy |
33,108
+400
| +1% | +$17.8K | 0.07% | 109 |
|
|
2019
Q4 | $1.4M | Sell |
32,708
-250
| -0.8% | -$10.7K | 0.06% | 118 |
|
|
2019
Q3 | $1.41M | Buy |
32,958
+250
| +0.8% | +$10.7K | 0.06% | 114 |
|
|
2019
Q2 | $2.08M | Hold |
32,708
| – | – | 0.09% | 107 |
|
|
2019
Q1 | $2.27M | Hold |
32,708
| – | – | 0.16% | 62 |
|
|
2018
Q4 | $1.42M | Sell |
32,708
-500
| -2% | -$21.7K | 0.11% | 68 |
|
|
2018
Q3 | $2.54M | Hold |
33,208
| – | – | 0.18% | 63 |
|
|
2018
Q2 | $2.54M | Buy |
33,208
+11,500
| +53% | +$880K | 0.18% | 62 |
|
|
2018
Q1 | $1.11M | Buy |
21,708
+500
| +2% | +$25.5K | 0.09% | 74 |
|
|
2017
Q4 | $984K | Hold |
21,208
| – | – | 0.08% | 79 |
|
|
2017
Q3 | $1.13M | Hold |
21,208
| – | – | 0.1% | 72 |
|
|
2017
Q2 | $1.42M | Hold |
21,208
| – | – | 0.12% | 70 |
|
|
2017
Q1 | $1.29M | Buy |
+21,208
| New | +$1.29M | 0.11% | 68 |
|